NASDAQ:ALGN - Align Technology Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $586.20
  • Forecasted Upside: 137.00 %
  • Number of Analysts: 11
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 11 Buy Ratings
  • 0 Strong Buy Ratings
▲ +10.67 (4.51%)

This chart shows the closing price for ALGN by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Align Technology Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ALGN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ALGN

Analyst Price Target is $586.20
▲ +137.00% Upside Potential
This price target is based on 11 analysts offering 12 month price targets for Align Technology in the last 3 months. The average price target is $586.20, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 137.00% upside from the last price of $247.34.

This chart shows the closing price for ALGN for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 11 contributing investment analysts is to buy stock in Align Technology. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 13 buy ratings
  • 1 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 11 buy ratings
  • 1 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 11 buy ratings
  • 1 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 13 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 12 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 13 buy ratings
  • 0 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 11 buy ratings
  • 0 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 11 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 11 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/15/2022Morgan StanleyLower Price TargetOverweight$524.00 ➝ $479.00Low
5/4/2022Credit Suisse GroupLower Price Target$722.00 ➝ $418.00Medium
4/28/2022Stifel NicolausLower Price Target$575.00 ➝ $425.00High
4/28/2022Morgan StanleyLower Price Target$575.00 ➝ $524.00High
4/28/2022Robert W. BairdLower Price TargetOutperform$625.00 ➝ $510.00High
4/28/2022Piper SandlerLower Price Target$600.00 ➝ $440.00High
4/26/2022UBS GroupLower Price TargetBuy$620.00 ➝ $500.00Medium
4/21/2022Piper SandlerLower Price TargetOverweight$740.00 ➝ $600.00High
2/3/2022Robert W. BairdLower Price Target$745.00 ➝ $650.00High
2/3/2022Stifel NicolausLower Price TargetBuy$675.00 ➝ $625.00High
2/3/2022Credit Suisse GroupLower Price TargetOutperform$782.00 ➝ $722.00High
1/31/2022UBS GroupUpgradeNeutral ➝ Buy$880.00 ➝ $620.00High
1/31/2022Morgan StanleyInitiated CoverageOverweight$575.00High
1/21/2022Stifel NicolausLower Price Target$750.00 ➝ $675.00High
11/1/2021William BlairReiterated RatingOutperformLow
10/28/2021The Goldman Sachs GroupDowngradeBuy$810.00High
10/28/2021Piper SandlerBoost Price TargetPositive ➝ Overweight$775.00 ➝ $825.00High
7/29/2021William BlairReiterated RatingOutperformHigh
7/29/2021Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$715.00 ➝ $732.00High
7/29/2021Piper SandlerBoost Price TargetOverweight$735.00 ➝ $775.00High
7/9/2021StephensUpgradeEqual Weight ➝ Overweight$600.00 ➝ $700.00Medium
7/8/2021Exane BNP ParibasInitiated CoverageOutperform$790.00Medium
7/8/2021BNP ParibasInitiated CoverageOutperform$790.00Medium
4/29/2021SVB LeerinkBoost Price TargetPositive ➝ Outperform$690.00 ➝ $770.00High
4/29/2021Credit Suisse GroupBoost Price TargetOutperform$693.00 ➝ $715.00High
4/29/2021Stifel NicolausBoost Price TargetBuy$650.00 ➝ $750.00High
4/29/2021Robert W. BairdBoost Price TargetOutperform$655.00 ➝ $745.00High
4/29/2021Piper SandlerBoost Price TargetOverweight$700.00 ➝ $735.00High
4/22/2021Berenberg BankUpgradeHold ➝ Buy$683.00Medium
4/15/2021SVB LeerinkBoost Price TargetOutperform$680.00 ➝ $690.00Medium
2/4/2021Evercore ISIBoost Price TargetOutperform$625.00 ➝ $680.00High
2/4/2021Credit Suisse GroupBoost Price TargetOutperform$618.00 ➝ $630.00High
2/4/2021SVB LeerinkBoost Price TargetOutperform$620.00 ➝ $680.00High
2/4/2021BarclaysBoost Price TargetEqual Weight$475.00 ➝ $555.00High
2/2/2021Piper SandlerBoost Price TargetOverweight$525.00 ➝ $610.00Low
1/4/2021Evercore ISIUpgradeIn-Line ➝ Outperform$625.00N/A
11/24/2020Credit Suisse GroupBoost Price TargetOutperform$432.00 ➝ $515.00Medium
11/24/2020SVB LeerinkBoost Price TargetOutperform$460.00 ➝ $520.00Medium
11/24/2020The Goldman Sachs GroupBoost Price TargetBuy$472.00 ➝ $535.00Medium
11/24/2020Robert W. BairdBoost Price TargetOutperform$450.00 ➝ $530.00Medium
11/23/2020Piper SandlerBoost Price TargetOverweight$500.00 ➝ $525.00Medium
10/28/2020Stifel NicolausBoost Price TargetBuy$460.00 ➝ $515.00Low
10/22/2020Robert W. BairdBoost Price Target$370.00 ➝ $450.00High
10/22/2020Stifel NicolausBoost Price TargetBuy$360.00 ➝ $460.00High
10/22/2020BarclaysBoost Price TargetEqual Weight$300.00 ➝ $400.00High
10/22/2020Piper SandlerBoost Price TargetOverweight$400.00 ➝ $500.00High
10/22/2020Jefferies Financial GroupBoost Price TargetBuy$355.00 ➝ $450.00High
10/22/2020Credit Suisse GroupBoost Price TargetOutperform$348.00 ➝ $432.00High
10/22/2020SVB LeerinkBoost Price TargetOutperform$340.00 ➝ $460.00High
7/29/2020Berenberg BankDowngradeBuy ➝ Hold$306.00Low
7/23/2020BarclaysDowngradeOverweight ➝ Equal Weight$225.00 ➝ $300.00High
7/23/2020SVB LeerinkBoost Price TargetOutperform$310.00 ➝ $340.00High
7/23/2020Piper SandlerBoost Price TargetOverweight$258.00 ➝ $345.00High
7/20/2020Bank of AmericaDowngradeNeutral ➝ Underperform$280.00Low
7/14/2020SVB LeerinkBoost Price TargetOutperform$260.00 ➝ $310.00High
6/12/2020OTR GlobalUpgradePositiveLow
6/12/2020Stifel NicolausBoost Price TargetBuy$275.00 ➝ $300.00Low
5/22/2020Stifel NicolausBoost Price TargetBuy$230.00 ➝ $275.00High
5/1/2020UBS GroupLower Price TargetNeutral$270.00 ➝ $245.00Low
4/30/2020SVB LeerinkReiterated RatingOutperformLow
4/30/2020Credit Suisse GroupLower Price TargetOutperform$320.00 ➝ $275.00Low
4/30/2020Robert W. BairdBoost Price TargetOutperform$225.00 ➝ $248.00Low
4/30/2020Piper SandlerLower Price TargetOverweight$275.00 ➝ $258.00Low
3/19/2020StephensLower Price TargetEqual Weight$220.00 ➝ $165.00High
3/13/2020Stifel NicolausLower Price TargetBuy$305.00 ➝ $275.00High
3/5/2020Robert W. BairdReiterated RatingBuy$325.00Medium
1/30/2020Piper SandlerBoost Price Target$240.00 ➝ $275.00Medium
1/28/2020UBS GroupBoost Price TargetNeutral$235.00 ➝ $280.00Medium
1/9/2020Wolfe ResearchUpgradePeer Perform ➝ Outperform$360.00Medium
11/19/2019StephensReiterated RatingHold$220.00Medium
11/18/2019Stifel NicolausBoost Price TargetBuy$290.00 ➝ $305.00Medium
10/24/2019Bank of AmericaBoost Price TargetNeutral$220.00 ➝ $240.00High
10/7/2019BarclaysLower Price TargetOverweight$300.00 ➝ $272.00High
10/7/2019GuggenheimDowngradeBuy ➝ Neutral$250.00 ➝ $200.00High
7/31/2019Piper Jaffray CompaniesSet Price TargetBuy$240.00N/A
7/26/2019UBS GroupSet Price TargetHold$230.00Medium
7/26/2019Robert W. BairdLower Price TargetOutperform$336.00 ➝ $259.00Medium
7/25/2019Stifel NicolausLower Price TargetBuy$360.00 ➝ $290.00Low
7/25/2019Bank of AmericaDowngradeBuy ➝ NeutralMedium
7/25/2019Credit Suisse GroupLower Price TargetOutperform$340.00 ➝ $320.00High
7/25/2019Piper Jaffray CompaniesLower Price TargetOverweight$350.00 ➝ $240.00High
5/30/2019Wolfe ResearchInitiated CoveragePeer Perform ➝ Peer PerformMedium
4/26/2019UBS GroupSet Price TargetHold$325.00Low
4/25/2019Credit Suisse GroupBoost Price TargetOutperform$305.00 ➝ $316.00High
4/25/2019BarclaysBoost Price TargetOverweight ➝ Overweight$335.00 ➝ $355.00Low
4/25/2019Piper Jaffray CompaniesBoost Price TargetOverweight$300.00 ➝ $350.00Medium
4/17/2019GuggenheimInitiated CoverageBuy ➝ Buy$335.00High
4/11/2019BarclaysSet Price TargetBuy$325.00Low
3/25/2019Credit Suisse GroupBoost Price TargetOutperform$270.00 ➝ $278.00Low
3/19/2019Piper Jaffray CompaniesBoost Price TargetOverweight$250.00 ➝ $300.00Medium
3/14/2019OTR GlobalDowngradePositiveLow
3/5/2019Robert W. BairdBoost Price TargetOutperform ➝ Outperform$255.00 ➝ $286.00High
2/14/2019UBS GroupDowngradeBuy ➝ Neutral$275.00Low
1/30/2019Credit Suisse GroupLower Price TargetOutperform$277.00 ➝ $270.00High
1/30/2019SVB LeerinkLower Price TargetOutperform$300.00 ➝ $285.00High
1/17/2019UBS GroupInitiated CoverageBuy ➝ Buy$230.00High
1/6/2019BarclaysReiterated RatingBuy$275.00Medium
1/4/2019Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$300.00 ➝ $210.00Low
1/2/2019Robert W. BairdLower Price TargetOutperform$330.00 ➝ $255.00High
11/20/2018Credit Suisse GroupLower Price TargetOutperform ➝ Outperform$375.00 ➝ $343.00High
11/19/2018William BlairReiterated RatingOutperformHigh
10/25/2018Morgan StanleyLower Price TargetEqual Weight$320.00 ➝ $300.00High
10/25/2018Credit Suisse GroupLower Price TargetOutperform$391.00 ➝ $375.00High
10/25/2018Robert W. BairdLower Price TargetOutperform$425.00 ➝ $330.00High
10/25/2018Stifel NicolausLower Price TargetAverage ➝ Buy$425.00 ➝ $346.00High
10/20/2018The Goldman Sachs GroupInitiated CoverageBuy$420.00Low
10/9/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$315.00 ➝ $320.00Low
7/26/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$340.00 ➝ $391.00Medium
7/26/2018SVB LeerinkBoost Price TargetOutperform$400.00 ➝ $420.00Medium
7/26/2018BarclaysReiterated RatingBuyHigh
7/26/2018Robert W. BairdBoost Price TargetOutperform$351.00 ➝ $425.00High
7/26/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$375.00 ➝ $425.00High
7/20/2018Piper Jaffray CompaniesBoost Price TargetOverweight$425.00Low
7/13/2018Morgan StanleyBoost Price TargetEqual Weight$290.00 ➝ $315.00Low
7/13/2018Stifel NicolausBoost Price TargetBuy$350.00 ➝ $375.00Low
6/26/2018Northcoast ResearchReiterated RatingBuy$430.00Low
6/25/2018Bank of AmericaInitiated CoverageBuy$420.00Low
6/21/2018BarclaysBoost Price TargetOverweight$410.00Medium
6/1/2018Stifel NicolausReiterated RatingBuy$320.00 ➝ $350.00Low
5/25/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$300.00 ➝ $340.00Low
5/24/2018Piper Jaffray CompaniesBoost Price TargetOverweight ➝ Overweight$300.00 ➝ $325.00High
5/24/2018Jefferies Financial GroupBoost Price TargetBuy$350.00High
5/24/2018SVB LeerinkBoost Price TargetOutperform ➝ Outperform$305.00 ➝ $360.00High
5/22/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$320.00 ➝ $350.00Medium
5/21/2018BarclaysBoost Price TargetOverweight ➝ Overweight$295.00 ➝ $325.00Medium
5/16/2018Evercore ISIInitiated CoverageOutperform$340.00Low
4/26/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$290.00 ➝ $300.00High
4/26/2018BarclaysBoost Price TargetOverweight ➝ Overweight$290.00 ➝ $295.00High
4/26/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$270.00 ➝ $290.00Low
4/26/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$295.00 ➝ $320.00Medium
4/20/2018Berenberg BankInitiated CoverageBuy$305.00High
4/19/2018Morgan StanleyReiterated RatingOverweight ➝ Equal Weight$220.00High
4/18/2018Morgan StanleyDowngradeOverweight ➝ Equal Weight$300.00 ➝ $270.00High
3/8/2018BarclaysInitiated CoverageOverweight ➝ Overweight$290.00Medium
1/31/2018Piper Jaffray CompaniesReiterated RatingBuy$300.00High
1/31/2018SVB LeerinkBoost Price TargetOutperform ➝ Outperform$300.00 ➝ $305.00Medium
1/31/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$276.00 ➝ $290.00Medium
1/30/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$265.00 ➝ $295.00High
1/19/2018StephensDowngradeOverweight ➝ Equal Weight$230.00Low
1/4/2018Credit Suisse GroupUpgradeBuy$276.00High
12/8/2017Deutsche Bank AktiengesellschaftInitiated CoverageHold ➝ Hold$250.00Low
11/29/2017Robert W. BairdReiterated RatingBuy$290.00Medium
11/28/2017Credit Suisse GroupReiterated RatingOutperform$261.00 ➝ $276.00Low
11/27/2017Morgan StanleyBoost Price TargetOverweight$257.00 ➝ $300.00High
11/21/2017Stifel NicolausBoost Price TargetBuy ➝ Buy$245.00 ➝ $265.00N/A
11/9/2017Credit Suisse GroupReiterated RatingOutperform ➝ Positive$209.00 ➝ $261.00N/A
10/27/2017Credit Suisse GroupBoost Price TargetOutperform$175.00 ➝ $209.00N/A
10/27/2017SVB LeerinkReiterated RatingOutperform$250.00N/A
10/27/2017Robert W. BairdReiterated RatingBuy$245.00N/A
10/23/2017Stifel NicolausBoost Price TargetBuy$205.00 ➝ $225.00N/A
10/19/2017Stifel NicolausReiterated RatingBuy ➝ Buy$205.00 ➝ $225.00N/A
10/18/2017Robert W. BairdSet Price TargetBuy$208.00N/A
10/10/2017Northcoast ResearchReiterated RatingBuy$200.00 ➝ $230.00N/A
10/6/2017Morgan StanleyReiterated RatingOverweight$195.00 ➝ $220.00N/A
9/15/2017The Goldman Sachs GroupBoost Price TargetBuy$185.00 ➝ $210.00Low
9/12/2017Robert W. BairdReiterated RatingBuyMedium
9/11/2017Piper Jaffray CompaniesReiterated RatingBuy$200.00Medium
8/7/2017Stifel NicolausReiterated RatingBuy$200.00 ➝ $205.00Low
7/28/2017SVB LeerinkReiterated RatingOutperform$194.00 ➝ $199.00Low
7/28/2017Piper Jaffray CompaniesReiterated RatingBuy$176.00High
7/28/2017Bank of AmericaUpgradeNeutral ➝ Buy$175.00 ➝ $193.00High
7/17/2017Morgan StanleyReiterated RatingOverweight$175.00 ➝ $182.00Low
7/13/2017Credit Suisse GroupReiterated RatingOutperform$140.00 ➝ $170.00Low
(Data available from 7/3/2017 forward)

News Sentiment Rating

0.14 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 12 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 0 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 2 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
  • 1 very positive mentions
  • 27 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 3 very positive mentions
  • 22 positive mentions
  • 8 negative mentions
  • 0 very negative mentions
  • 4 very positive mentions
  • 18 positive mentions
  • 2 negative mentions
  • 2 very negative mentions
  • 1 very positive mentions
  • 5 positive mentions
  • 3 negative mentions
  • 1 very negative mentions

Current Sentiment

  • 1 very positive mentions
  • 5 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
Align Technology logo
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
Read More

Today's Range

Now: $247.34
Low: $235.28
High: $247.67

50 Day Range

MA: $271.71
Low: $229.82
High: $368.86

52 Week Range

Now: $247.34
Low: $225.86
High: $737.45


682,031 shs

Average Volume

1,138,155 shs

Market Capitalization

$19.49 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Align Technology?

The following equities research analysts have issued stock ratings on Align Technology in the last twelve months: BNP Paribas, Credit Suisse Group AG, Exane BNP Paribas, Morgan Stanley, Piper Sandler, Robert W. Baird, Stephens, Stifel Nicolaus,, The Goldman Sachs Group, Inc., TheStreet, UBS Group AG, and William Blair.
View the latest analyst ratings for ALGN.

What is the current price target for Align Technology?

0 Wall Street analysts have set twelve-month price targets for Align Technology in the last year. Their average twelve-month price target is $586.20, suggesting a possible upside of 137.0%.
View the latest price targets for ALGN.

What is the current consensus analyst rating for Align Technology?

Align Technology currently has 11 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ALGN will outperform the market and that investors should add to their positions of Align Technology.
View the latest ratings for ALGN.

How do I contact Align Technology's investor relations team?

Align Technology's physical mailing address is 2820 ORCHARD PARKWAY, SAN JOSE CA, 95134. The medical equipment provider's listed phone number is (408) 470-1000 and its investor relations email address is [email protected] The official website for Align Technology is Learn More about contacing Align Technology investor relations.